Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The purpose of this study is
to determine if the use of insulin detemir in combination with insulin aspart is safe and at
least as effective as insulin glargine in combination with insulin aspart for the control of
blood glucose in patients with Type 2 diabetes.